Further to the announcement made by MMJ Group Holdings Limited (ASX:MMJ) (FRA:2P9) (OTCMKTS:MMJJF) (“MMJ”) on 3 December 2018 regarding its shareholding in Harvest One Cannabis Inc. (CVE:HVT) (“Harvest One”), the board of directors of MMJ (“MMJ Board”) wishes to advise that its current strategy is to remain a major shareholder of Harvest One and support its management team in the execution of its business plan.

In this regard, the MMJ Board notes that Harvest One appointed a new Chief Executive Officer, Chief Operating Officer and General Counsel, and members to the Company’s Board of Directors during the last fiscal quarter 2019. This new team is in the process of executing a revised strategic direction for Harvest One, which includes:

– A 13,000 square foot expansion already underway of United Greeneries’ primary operations in Duncan, British Columbia that will triple the output of the facility;

– Continued construction of a 60,000 square foot indoor flowering facility at its Lucky Lake property in Saskatchewan;

– Driving sales growth for Satipharm including the Gelpell(R) Microgel capsules in the EU and as Harvest One’s primary brand for medical offerings throughout Canada;

– Continued sales growth of the Dream Water product ranges (which incurred record revenue growth for the last fiscal quarter) and development of cannabinoid infused product lines for the North American market;

– Furthering other commercial transactions, such as the multi-year Extraction Services Agreement with Valens GroWorks Corp. for cannabis extraction and value-added services and the investment in Burb, a new BC-based retailer of cannabis and cannabis-related products; and

– Harvest One also remains extremely well capitalised with approximately CAD$48 million in cash at the end of the last quarter.

MMJ owns 55,557,994 shares in Harvest One for a 30.5% shareholding and this remains MMJ’s most significant investment to date.

The MMJ Board is confident that the Harvest One management team will execute on its future business plan and that this should lead to an increase in the value of MMJ’s shareholding in Harvest One.

About MMJ Group Holdings Ltd

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ’s latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/

Click here to connect with Harvest One (TSXV:HVT) for an Investor Presentation.

Source: www.abnnewswire.net

Trading resumes in:

Company: Revive Therapeutics Ltd.

Keep reading... Show less


Revive Therapeutics Ltd. (” Revive ” or the ” Company “) (CSE:RVV) ( USA : RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce that it has entered into an amended agreement with Canaccord Genuity Corp. and Leede Jones Gable Inc. as the co-lead underwriters (collectively, the ” Underwriters “), to increase the size of its previously announced offering of units (the ” Equity Units “) at a price of $0.50 per Equity Unit. Under the amended terms, the Underwriters have agreed to purchase, on a bought deal basis, 40,000,000 Equity Units for gross proceeds to the Company of $20,000,000 (the ” Offering “). The over-allotment option granted to the Underwriters will proportionately increase to 15% of the Offering.

Keep reading... Show less

The new dispensary brings expanded access for patients in the growing communities of Central Florida

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 77th nationwide. The new, 5,100 sq. ft. location marks the Company’s first in Summerfield expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”).

The Company announced today that its board of directors have approved a private placement of up to 15,000,000 units at a price of $.40 per unit for gross proceeds of up to $6,000,000. Each unit will consist of one common share of the Company and one share purchase warrant. Each share purchase warrant will be exercisable to purchase an additional common share at a fixed price of $.45 per share for a period of one year from closing.

Keep reading... Show less

The following issues have been halted by IIROC:

Company: Revive Therapeutics Ltd.

Keep reading... Show less